Atlas Trials

A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With Schizophrenia

Clinical trial NCT00538070 · COMPLETED

Trial details

NCT number
NCT00538070
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Schizophrenia
Start date
2007-08-01
Primary completion
2012-07-01
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.